Related Experiment Video

Updated: Jun 6, 2026

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
08:12

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets

Published on: September 6, 2019

The clinical care of the HIV-1-infected infant

Andres F Camacho-Gonzalez1, Allison C Ross, Rana Chakraborty

  • 1Division of Pediatric Infectious Diseases, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University, 2015 Uppergate Drive, Suite 500, Atlanta, GA 30322, USA.

Clinics in Perinatology
|November 17, 2010
PubMed

Insights

New HIV-1 infections in infants still occur globally. Early antiretroviral therapy and Pneumocystis pneumonia prophylaxis are crucial for managing established infant HIV-1 infection and reducing disease progression.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Mother-to-child transmission of Human Immunodeficiency Virus type 1 (HIV-1) remains a global health concern.
  • Disparities in healthcare access contribute to ongoing perinatal HIV-1 infections.
  • Established HIV-1 infection in infants requires prompt and effective management.

Purpose of the Study:

  • To review current recommendations for the treatment of HIV-1-infected infants.
  • To summarize the evidence supporting treatment strategies for pediatric HIV-1.
  • To highlight the importance of timely intervention in reducing disease progression.

Main Methods:

  • Literature review of existing guidelines and clinical studies.
  • Analysis of evidence for antiretroviral therapy (ART) in infants.
  • Examination of prophylaxis strategies for opportunistic infections, specifically Pneumocystis jiroveci pneumonia (PCP).

Main Results:

  • Early initiation of ART is critical for controlling viral load and preventing immune deterioration.
  • Prophylaxis against PCP significantly reduces the risk of severe illness and mortality in HIV-1-infected infants.
  • Combination therapy demonstrates the most effective outcomes.

Conclusions:

  • Aggressive treatment strategies, including early ART and PCP prophylaxis, are essential for improving outcomes in HIV-1-infected infants.
  • Addressing healthcare access disparities is vital to further reduce perinatal HIV-1 transmission.
  • Continued research and adherence to evidence-based guidelines are necessary for optimal pediatric HIV care.

More Related Videos

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...